#188 - Demystifying PBMs and Transparent Pharmacy Benefits

In this eye-opening episode of The ASHHRA Podcast, hosts Bo Brabo and Luke Carignan welcome Kinjal Patel and Brady Heiner from RxBenefits to demystify the complex world of pharmacy benefit management (PBMs). As costs skyrocket, driven by specialty drugs accounting for 50% of spend from just 2% of prescriptions, HR leaders face fiduciary risks, hidden contract clauses, and potential class-action lawsuits. Kinjal and Brady reveal how transparent PBMs differ from traditional models, why "transparency" claims often fall short, and how RxBenefits operates as a client-aligned Pharmacy Benefits Optimizer with 3 million members' negotiating power.

Discover actionable strategies for hospitals and health systems to leverage in-house pharmacies, avoid rebate pitfalls, and conduct essential market checks and audits. The duo emphasizes the critical fine print in PBM contracts (e.g., CVS, Express Scripts, OptumRx) that can erode savings if overlooked. RxBenefits offers free, comprehensive contract analyses to uncover hidden opportunities and protect your organization.

Key takeaways for healthcare HR professionals:

• Understand true PBM transparency vs. marketing hype… demand bias-free alignment.
• Specialty drugs dominate costs; optimize high-dollar prescriptions for massive savings.
• Hospital pharmacies are goldmines; structure contracts to maximize rebates and utilization.
• Fiduciary duty demands expertise; avoid legal risks with proactive audits.
• Don't DIY pharmacy benefits; partner with consultants for smarter plan design and pricing.

A must-listen for HR managing escalating drug spend and compliance. Take control… request your free RxBenefits analysis today!